NCT05530668View on ClinicalTrials.gov

Tolerance and Potential Synergistic Effect of the Combination of Intranasal Esketamine and Non-selective MAOI

CompletedOBSERVATIONAL

Enrollment

13

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

September 11, 2022

Study Completion Date

December 11, 2022

Conditions

Depression Anxiety Disorder

Trial Locations (1)

67091

Service de physiologie - Explorations fonctionnelles - CHU de Strasbourg - France, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER